Cargando…

Comparison of the efficacy of Gd-EOB-DTPA-enhanced magnetic resonance imaging and magnetic resonance elastography in the detection and staging of hepatic fibrosis

The present study compared the efficacy of gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance imaging (MRI) and magnetic resonance elastography (MRE) in the estimation of hepatic fibrosis stages with histopathologic correlation. This retrospective s...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Wen-Pei, Hoi, Cheng-In, Chen, Ran-Chou, Lin, Ching-Po, Chou, Chen-Te
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5662416/
https://www.ncbi.nlm.nih.gov/pubmed/29049250
http://dx.doi.org/10.1097/MD.0000000000008339
_version_ 1783274640070672384
author Wu, Wen-Pei
Hoi, Cheng-In
Chen, Ran-Chou
Lin, Ching-Po
Chou, Chen-Te
author_facet Wu, Wen-Pei
Hoi, Cheng-In
Chen, Ran-Chou
Lin, Ching-Po
Chou, Chen-Te
author_sort Wu, Wen-Pei
collection PubMed
description The present study compared the efficacy of gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance imaging (MRI) and magnetic resonance elastography (MRE) in the estimation of hepatic fibrosis stages with histopathologic correlation. This retrospective study included 104 patients (87 men and 17 women; mean age, 60.6 ± 10.6 years) with chronic liver disease who underwent both Gd-EOB-DTPA-enhanced MRI and MRE. The relative enhancement (RE) ratio of the liver parenchyma and the contrast enhancement index (CEI) were calculated as (SI(postliver) − SI(preliver))/SI(preliver) and SI(post)/SI(pre), respectively, where SI(post) and SI(pre) were the liver-to-muscle signal intensity ratios on the hepatobiliary phase images and noncontrast-enhanced images, respectively. The liver stiffness values were measured using MRE stiffness maps. The diagnostic performance of MRE, RE ratios, and CEI values for hepatic fibrosis staging were compared. The distribution of fibrosis stages was as follows: F0, n = 3 (2.9%); F1, n = 12 (11.5%); F2, n = 17 (16.3%); F3, n = 26 (25.0%); and F4, n = 46 (44.2%). MRE, RE ratios, and CEI values correlated significantly with hepatic fibrosis (r(s) = .79, −.35, −.25, respectively, P < .05). MRE showed a significantly higher diagnostic performance than did RE ratios and CEI values for each fibrosis stage, except while distinguishing the F1 fibrosis stage (CEI, P = .15). A cutoff value of RE ratio = 0.89 can be used to identify patients with significant hepatic fibrosis, with positive predictive value, sensitivity, specificity, and negative predictive value of 93.2%, 61.8%, 73.3%, and 24.4%, respectively. Gd-EOB-DTPA-enhanced MRI can potentially predict significant hepatic fibrosis. However, the diagnostic performance of MRE for hepatic fibrosis staging was superior to that of Gd-EOB-DTPA-enhanced MRI.
format Online
Article
Text
id pubmed-5662416
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-56624162017-11-21 Comparison of the efficacy of Gd-EOB-DTPA-enhanced magnetic resonance imaging and magnetic resonance elastography in the detection and staging of hepatic fibrosis Wu, Wen-Pei Hoi, Cheng-In Chen, Ran-Chou Lin, Ching-Po Chou, Chen-Te Medicine (Baltimore) 6800 The present study compared the efficacy of gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance imaging (MRI) and magnetic resonance elastography (MRE) in the estimation of hepatic fibrosis stages with histopathologic correlation. This retrospective study included 104 patients (87 men and 17 women; mean age, 60.6 ± 10.6 years) with chronic liver disease who underwent both Gd-EOB-DTPA-enhanced MRI and MRE. The relative enhancement (RE) ratio of the liver parenchyma and the contrast enhancement index (CEI) were calculated as (SI(postliver) − SI(preliver))/SI(preliver) and SI(post)/SI(pre), respectively, where SI(post) and SI(pre) were the liver-to-muscle signal intensity ratios on the hepatobiliary phase images and noncontrast-enhanced images, respectively. The liver stiffness values were measured using MRE stiffness maps. The diagnostic performance of MRE, RE ratios, and CEI values for hepatic fibrosis staging were compared. The distribution of fibrosis stages was as follows: F0, n = 3 (2.9%); F1, n = 12 (11.5%); F2, n = 17 (16.3%); F3, n = 26 (25.0%); and F4, n = 46 (44.2%). MRE, RE ratios, and CEI values correlated significantly with hepatic fibrosis (r(s) = .79, −.35, −.25, respectively, P < .05). MRE showed a significantly higher diagnostic performance than did RE ratios and CEI values for each fibrosis stage, except while distinguishing the F1 fibrosis stage (CEI, P = .15). A cutoff value of RE ratio = 0.89 can be used to identify patients with significant hepatic fibrosis, with positive predictive value, sensitivity, specificity, and negative predictive value of 93.2%, 61.8%, 73.3%, and 24.4%, respectively. Gd-EOB-DTPA-enhanced MRI can potentially predict significant hepatic fibrosis. However, the diagnostic performance of MRE for hepatic fibrosis staging was superior to that of Gd-EOB-DTPA-enhanced MRI. Wolters Kluwer Health 2017-10-20 /pmc/articles/PMC5662416/ /pubmed/29049250 http://dx.doi.org/10.1097/MD.0000000000008339 Text en Copyright © 2017 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nd/4.0 This is an open access article distributed under the Creative Commons Attribution-NoDerivatives License 4.0, which allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author. http://creativecommons.org/licenses/by-nd/4.0
spellingShingle 6800
Wu, Wen-Pei
Hoi, Cheng-In
Chen, Ran-Chou
Lin, Ching-Po
Chou, Chen-Te
Comparison of the efficacy of Gd-EOB-DTPA-enhanced magnetic resonance imaging and magnetic resonance elastography in the detection and staging of hepatic fibrosis
title Comparison of the efficacy of Gd-EOB-DTPA-enhanced magnetic resonance imaging and magnetic resonance elastography in the detection and staging of hepatic fibrosis
title_full Comparison of the efficacy of Gd-EOB-DTPA-enhanced magnetic resonance imaging and magnetic resonance elastography in the detection and staging of hepatic fibrosis
title_fullStr Comparison of the efficacy of Gd-EOB-DTPA-enhanced magnetic resonance imaging and magnetic resonance elastography in the detection and staging of hepatic fibrosis
title_full_unstemmed Comparison of the efficacy of Gd-EOB-DTPA-enhanced magnetic resonance imaging and magnetic resonance elastography in the detection and staging of hepatic fibrosis
title_short Comparison of the efficacy of Gd-EOB-DTPA-enhanced magnetic resonance imaging and magnetic resonance elastography in the detection and staging of hepatic fibrosis
title_sort comparison of the efficacy of gd-eob-dtpa-enhanced magnetic resonance imaging and magnetic resonance elastography in the detection and staging of hepatic fibrosis
topic 6800
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5662416/
https://www.ncbi.nlm.nih.gov/pubmed/29049250
http://dx.doi.org/10.1097/MD.0000000000008339
work_keys_str_mv AT wuwenpei comparisonoftheefficacyofgdeobdtpaenhancedmagneticresonanceimagingandmagneticresonanceelastographyinthedetectionandstagingofhepaticfibrosis
AT hoichengin comparisonoftheefficacyofgdeobdtpaenhancedmagneticresonanceimagingandmagneticresonanceelastographyinthedetectionandstagingofhepaticfibrosis
AT chenranchou comparisonoftheefficacyofgdeobdtpaenhancedmagneticresonanceimagingandmagneticresonanceelastographyinthedetectionandstagingofhepaticfibrosis
AT linchingpo comparisonoftheefficacyofgdeobdtpaenhancedmagneticresonanceimagingandmagneticresonanceelastographyinthedetectionandstagingofhepaticfibrosis
AT chouchente comparisonoftheefficacyofgdeobdtpaenhancedmagneticresonanceimagingandmagneticresonanceelastographyinthedetectionandstagingofhepaticfibrosis